Supplemental Figure 1 from Manipulating the Tumor Microenvironment <i>Ex Vivo</i> for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy

Supplemental Figure 1. Detection of 4-1BB on CD8+ T cells within fresh melanoma tumor fragments and in early tumor fragment cultures.</p

supplemental figure legend from Manipulating the Tumor Microenvironment <i>Ex Vivo</i> for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy

supplemental figure legend</p

Supplemental Figure 2 from Manipulating the Tumor Microenvironment <i>Ex Vivo</i> for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy

Supplemental Figure 2. Testing of different concentrations of agonist anti-4-1BB antibody added to melanoma tumor fragment cultures.</p

Supplementary Materials, Tables 1-2, Figures 1-11 from The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms

PDF file - 1.0MB</p

CCR Translation for This Article from The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms

CCR Translation for This Article from The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanism

Supplementary Data from BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells

Supplemental Figure 1. Temporal regulation and the effect of combination of B-raf inhibitor on M6PR expression. Supplemental Figure 2. Effect of combination of B-raf and MEK inhibitors on M6PR expression. Supplemental Figure 3. WM35 cells resistant to PLX4720. Supplemental Figure 4. Effect of M6PR overexpression and deletion on melanoma cell sensitivity to PLX4720 in MTT test. Supplemental Figure 5. Expression of surface molecules on melanoma cells with manipulated expression of M6PR. Supplemental Table 1 Clinical characteristics of patients enrolled to the study Supplemental Table 2. Grade 3+ Adverse Events in treated patients</p

Supplementary Data from <i>PTPN11</i> Plays Oncogenic Roles and Is a Therapeutic Target for <i>BRAF</i> Wild-Type Melanomas

Supplementary information and data, Supplementary figures 1-14</p

Supplementary Data from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy

Supplementary Data from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherap

Supplementary Figure from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy

Supplementary Figure from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherap

Supplementary Figure from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherapy

Supplementary Figure from Single-cell Characterization of the Cellular Landscape of Acral Melanoma Identifies Novel Targets for Immunotherap